165 related articles for article (PubMed ID: 18430791)
1. Confirmed beta16 Arg/Arg polymorphism in a patient with uncontrolled asthma.
Metzger NL; Kockler DR; Gravatt LA
Ann Pharmacother; 2008 Jun; 42(6):874-81. PubMed ID: 18430791
[TBL] [Abstract][Full Text] [Related]
2. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
3. Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N; Yoshikawa T; Kanazawa H; Hirata K; Fujimoto S
Respirology; 2008 May; 13(3):346-52. PubMed ID: 18399855
[TBL] [Abstract][Full Text] [Related]
4. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
[TBL] [Abstract][Full Text] [Related]
5. The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN
Am J Respir Crit Care Med; 2000 Jul; 162(1):75-80. PubMed ID: 10903223
[TBL] [Abstract][Full Text] [Related]
6. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
7. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
8. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
9. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
Drescher GS; Carnathan BJ; Imus S; Colice GL
Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
[TBL] [Abstract][Full Text] [Related]
10. A safety review of long-acting beta2-agonists in patients with asthma.
Rider NL; Craig TJ
J Am Osteopath Assoc; 2006 Sep; 106(9):562-7. PubMed ID: 17079526
[TBL] [Abstract][Full Text] [Related]
11. Clinical consequences of ADRbeta2 polymorphisms.
Hawkins GA; Weiss ST; Bleecker ER
Pharmacogenomics; 2008 Mar; 9(3):349-58. PubMed ID: 18303970
[TBL] [Abstract][Full Text] [Related]
12. Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children.
Giubergia V; Gravina LP; Castaños C; Chertkoff L; Grenoville M
Pediatr Pulmonol; 2008 May; 43(5):421-5. PubMed ID: 18383333
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of beta agonists.
Donohue JF
Respir Care; 2008 May; 53(5):618-22; discussion 623-4. PubMed ID: 18426615
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
15. High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study.
Thomas M; von Ziegenweidt J; Lee AJ; Price D
J Allergy Clin Immunol; 2009 Jan; 123(1):116-121.e10. PubMed ID: 18986690
[TBL] [Abstract][Full Text] [Related]
16. Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.
Israel E; Drazen JM; Liggett SB; Boushey HA; Cherniack RM; Chinchilli VM; Cooper DM; Fahy JV; Fish JE; Ford JG; Kraft M; Kunselman S; Lazarus SC; Lemanske RF; Martin RJ; McLean DE; Peters SP; Silverman EK; Sorkness CA; Szefler SJ; Weiss ST; Yandava CN;
Int Arch Allergy Immunol; 2001; 124(1-3):183-6. PubMed ID: 11306963
[TBL] [Abstract][Full Text] [Related]
17. Beta2-adrenoceptor polymorphisms predict response to beta2-agonists in children with acute asthma.
Martin AC; Zhang G; Rueter K; Khoo SK; Bizzintino J; Hayden CM; Geelhoed GC; Goldblatt J; Laing IA; Le Souëf PN
J Asthma; 2008 Jun; 45(5):383-8. PubMed ID: 18569231
[TBL] [Abstract][Full Text] [Related]
18. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
19. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
Lipworth BJ
Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
[TBL] [Abstract][Full Text] [Related]
20. [Polymorphism of beta 2-adrenergic receptors].
Weglarz L; Grzanka A; Kierot J; Wilczok T
Wiad Lek; 2003; 56(5-6):283-8. PubMed ID: 14526489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
